Home

Johnson & Johnson (JNJ)

177.20
+0.74 (0.42%)
NYSE · Last Trade: Sep 17th, 4:32 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close176.46
Open176.71
Bid177.00
Ask177.19
Day's Range176.59 - 178.51
52 Week Range140.68 - 181.16
Volume6,632,269
Market Cap465.80B
PE Ratio (TTM)-
EPS (TTM)-
Dividend & Yield5.200 (2.93%)
1 Month Average Volume7,710,913

Chart

About Johnson & Johnson (JNJ)

Johnson & Johnson is a multinational corporation engaged in the development, manufacturing, and marketing of a wide range of healthcare products. The company operates through three primary segments: pharmaceuticals, medical devices, and consumer health products. Johnson & Johnson is known for its commitment to innovation in healthcare, producing a diverse array of products that include prescription medications for various diseases, sophisticated medical devices for surgical procedures, and widely recognized consumer brands for personal care and wellness. With a focus on improving health outcomes, the company aims to address the evolving needs of patients and consumers around the world. Read More

News & Press Releases

Johnson & Johnson, Protagonist Study Shows Superior Skin Clearance In Psoriasis Trialsbenzinga.com
Johnson & Johnson and Protagonist Therapeutics announced new data from their Phase 3 studies to treat severe plaque psoriasis.
Via Benzinga · September 17, 2025
Intuitive Surgical's Stellar Q2 2025 Performance Propels Robotic Surgery Market Forward
Sunnyvale, CA – September 17, 2025 – Intuitive Surgical (NASDAQ: ISRG), the pioneer and global leader in robotic-assisted surgery, has once again demonstrated its formidable market position with a robust second-quarter 2025 earnings report. The company announced an impressive adjusted Earnings Per Share (EPS) of $2.19, significantly surpassing analyst expectations, coupled
Via MarketMinute · September 17, 2025
A Precarious Ascent: Stock Market Bulls Grapple with Stubborn Inflation and a Cooling Job Market
The financial markets find themselves in a fascinating, if precarious, dance. Despite a recent surge in stock market performance, with the S&P 500 ([SPX]) registering robust gains in recent years, underlying economic currents are flashing amber. Persistent inflationary pressures continue to gnaw at purchasing power, while a noticeable deceleration
Via MarketMinute · September 17, 2025
J&J’s Investigational Plaque Psoriasis Drug Outperforms Bristol Myers’ Sotyktu In Studystocktwits.com
Via Stocktwits · September 17, 2025
Big Pharma Eyes China: J&J And Roche Reportedly In Talks For Henlius’ Experimental Cancer Drugstocktwits.com
Via Stocktwits · September 15, 2025
Johnson & Johnson (NYSE:JNJ): A Dividend Stock with Lasting Financial Strengthchartmill.com
Johnson & Johnson (JNJ) is a top dividend stock with a 2.91% yield, over 10 years of growth, and strong financials for reliable income.
Via Chartmill · September 17, 2025
GSK Stock Climbs After-Hours On $30B US Investment Pledge As Trump Pressures Big Pharma To Build In Americastocktwits.com
The plan includes $1.2 billion for a new biologics factory in Upper Merion, Pennsylvania, along with AI upgrades and expanded drug production across existing U.S. sites.
Via Stocktwits · September 16, 2025
Navigating the Storm: Investment Strategies for an Unpredictable 2025
The financial landscape is bracing for a turbulent 2025, as expert consensus points towards a significant uptick in market volatility. This anticipated shift, driven by a complex interplay of global policies, stubbornly high inflation, and persistent geopolitical tensions, signals a departure from recent market dynamics, demanding a proactive and adaptable
Via MarketMinute · September 16, 2025
3 Dividend Stocks to Hold Through Market Volatility This Fallmarketbeat.com
Interest rate cuts may not decrease market volatility; discover three dividend stocks that can deliver stability, income, and growth during this fall
Via MarketBeat · September 16, 2025
Monetary Easing on the Horizon: Investors Brace for 2025 Rate Cuts, Fueling a Shift to Risk Assets
Central banks worldwide, spearheaded by the U.S. Federal Reserve, are signaling a significant pivot towards monetary easing in 2025. This anticipated shift, driven by a weakening labor market and cooling inflation, is poised to reshape financial markets and investor strategies. With lower borrowing costs on the horizon, a "risk-on"
Via MarketMinute · September 16, 2025
Market Mania Meets Economic Malaise: Record Highs Clash with Persistent Headwinds in Q3 2025
The third quarter of 2025 has been a period of stark contrasts for the global financial markets. While major U.S. stock indices like the S&P 500 and the Dow Jones Industrial Average (DJIA) have soared to unprecedented record highs, a closer look reveals a landscape fraught with economic
Via MarketMinute · September 16, 2025
3 Dividend-Paying ETFs to Buy in September Even If the S&P 500 Sells Offfool.com
Dividend-paying growth stocks and covered call ETFs provide opportunities to generate income even in a declining stock market.
Via The Motley Fool · September 16, 2025
3 Dividend Growers That Fly Under the Radarmarketbeat.com
These three companies may have what it takes to continue to build on their strong history of dividend payments even if the economy continues to sour.
Via MarketBeat · September 15, 2025
A Gathering Storm: U.S. Economy Grapples with Recessionary Headwinds
The United States economy is facing an increasingly complex and concerning confluence of risk factors, raising the specter of a looming recession. A deteriorating labor market, persistently high inflation, and the ongoing, disruptive impact of trade tariffs are interacting in ways that significantly elevate economic uncertainty for businesses, consumers, and
Via MarketMinute · September 15, 2025
Navigating the Shifting Sands: A Comprehensive Economic Outlook for 2025
As the global economy marches into 2025, it finds itself at a critical juncture, balancing the promise of moderate growth against the persistent shadows of tenacious inflation, geopolitical instability, and evolving labor market dynamics. This year is set to be defined by a complex interplay of forces that will shape
Via MarketMinute · September 15, 2025
Recession Radar: A Divergent Outlook on America's Economic Future
The U.S. economy finds itself at a crossroads, with leading financial institutions and economic forecasters presenting a varied, yet generally cautious, outlook on the probability of a recession. From machine learning algorithms to traditional yield curve models, the consensus is that while a severe downturn isn't a foregone conclusion,
Via MarketMinute · September 15, 2025
Stalling Job Market Rings Alarm Bells: August Employment Data Signals Economic Headwinds and Intensified Rate Cut Expectations
The latest U.S. employment report for August 2025 has sent a palpable chill through financial markets and economic forecasts, confirming a significant deceleration in the nation's labor market. Following a rare job contraction in June—the first monthly decline in nonfarm jobs since December 2020—the unemployment rate has
Via MarketMinute · September 15, 2025
Federal Reserve's Unexpected September Hold: A Looming Market Shock and an Estimated 8% S&P 500 Plunge
Financial markets are currently on edge, grappling with the looming possibility of a significant shock: an unexpected decision by the Federal Reserve to forgo a widely anticipated interest rate cut in September 2025. This deviation from market consensus, which largely projects a 25-basis-point reduction, could trigger a sharp negative reaction
Via MarketMinute · September 15, 2025
September's Shadow: Will the Notorious 'September Effect' Offer Bargains or Bring Bigger Bears to Wall Street?
As autumn leaves begin to fall, a familiar chill often descends upon the financial markets, not just in temperature but in investor sentiment. September has historically earned a notorious reputation among traders and analysts as the weakest month for equities, a phenomenon widely dubbed the "September Effect." This recurring statistical
Via MarketMinute · September 15, 2025
S&P 500's 22x Forward P/E: A Precarious Peak or Justified Premium?
The S&P 500's current forward price-to-earnings (P/E) ratio, hovering around 22x, has ignited a fervent debate across financial markets. This elevated valuation metric, significantly above historical averages, is prompting investors and analysts to question whether the market is perched precariously on a speculative bubble or if a new
Via MarketMinute · September 15, 2025
If You'd Invested $1,000 in Johnson & Johnson (JNJ) Stock 5 Years Ago, Here's How Much You'd Have Todayfool.com
The answer might surprise you.
Via The Motley Fool · September 15, 2025
Navigating the Storm: Diversification and Hedging Amidst Unprecedented Market Volatility
The global financial landscape is currently grappling with a potent concoction of heightened market instability, pervasive policy uncertainty, and an escalating array of geopolitical events. These formidable forces are collectively reshaping investment strategies and underscoring the critical need for robust diversification and strategic hedging within portfolios. As investors navigate these
Via MarketMinute · September 12, 2025
The Lingering Shadow: Sticky Inflation and Central Banks' Tightrope Walk in 2025
Global financial markets in 2025 are navigating a complex landscape shaped by persistently high, or "sticky," inflation and the increasingly cautious stance of major central banks regarding interest rate adjustments. Despite initial hopes for a swift return to pre-pandemic price stability, inflation, particularly in the services sector and fueled by
Via MarketMinute · September 12, 2025
The Dawn of a New Era: How GLP-1s, AI, and Robotic Surgery Are Reshaping Healthcare and Investment
The healthcare industry is currently experiencing a transformative "golden age," a period marked by an unprecedented surge in scientific breakthroughs and technological advancements. This era is fundamentally altering the landscape of medical treatment and diagnostics, promising a future of more personalized, precise, and preventive medicine. At the forefront of this
Via MarketMinute · September 12, 2025
Income Under Pressure: Why Covered Calls Are Capturing Investor Attention in Turbulent Markets
In an era defined by persistent market volatility and an ongoing search for reliable income streams, a historically potent, yet sometimes overlooked, options strategy is experiencing a significant resurgence: the covered call. As global financial markets navigate a landscape shaped by inflation concerns, fluctuating interest rates, and geopolitical uncertainties, investors
Via MarketMinute · September 12, 2025